Ametris is at the forefront of transforming clinical research through innovative digital solutions. Founded in 2004 and initially known for pioneering actigraphy wearables, Ametris has evolved into a comprehensive digital health provider that equips life sciences organizations with end-to-end platforms for bringing life-saving drugs to market efficiently. Their offerings encompass advanced wearable technologies, scientific consultation, regulatory compliance, and analytics, enabling researchers to harness complex real-world data effectively.

Ametris specializes in a variety of therapeutic areas, including oncology, respiratory health, and neurology, ensuring that their tools and insights enhance every phase of clinical trials. The company's commitment to scientific rigor and meaningful data translates into actionable insights that improve patient outcomes. Collaborating with partners in pre-competitive environments, Ametris drives innovation in digital endpoints and works to close evidence gaps within underserved populations. With a customer-centric approach and a dedication to equitable access, Ametris is shaping the future of healthcare by advancing meaningful research through digital transformation.